SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Balance Sheets (USD $)	Sep. 30, 2011	Dec. 31, 2010
CURRENT ASSETS
Cash	$ 934	$ 1,195
Accounts receivable	0	28,000
Total Current Assets	934	29,195
PROPERTY AND EQUIPMENT, NET	328	463
TOTAL ASSETS	1,262	29,658
CURRENT LIABILITIES
Accounts payable	262,054	244,359
Accrued interest	7,947	2,330
Related party payable	308,141	182,675
Notes payable	166,200	29,700
Accrued compensation	0	6,075
Total Current Liabilities	744,342	465,139
Total Liabilities	744,342	465,139
SHAREHOLDERS' DEFICIT
Preferred stock, 10,000,000 shares authorized of $0.001 par value, 75,000 and 150,000 shares issued and outstanding, respectively	75	150
Common stock, 200,000,000 shares authorized of $0.001 par value, 7,246,822 and 6,682,072 shares issued and outstanding, respectively	7,247	6,682
Additional paid in capital	9,727,714	8,697,935
Preferred stock subscribed	0	8,500
Deficit accumulated during the development stage	(10,478,116)	(9,148,748)
Total Shareholders' Deficit	(743,080)	(435,481)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 1,262	$ 29,658